Neuroblastoma is a neural crest cell-derived pediatric tumor characterized by high interand intra-tumor heterogeneity, and by a poor outcome in advanced stages. Patient-derived xenografts (PDXs) have been shown to be useful models for preserving and expanding original patient biopsies in vivo, and for studying neuroblastoma biology in a more...
-
June 7, 2023 (v1)PublicationUploaded on: June 9, 2023
-
October 19, 2021 (v1)PublicationIdentification of vrk1 as a new neuroblastoma tumor progression marker regulating cell proliferation
Neuroblastoma (NB) is one of the most common pediatric cancers and presents a poor survival rate in affected children. Current pretreatment risk assessment relies on a few known molecular parameters, like the amplification of the oncogene MYCN. However, a better molecular knowledge about the aggressive progression of the disease is needed to...
Uploaded on: March 25, 2023